Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptor activation

Journal of Physiology

Volumn 492, Issue 1, 1996, Pages 143-154

  Harvey, Jenni ^a   Lacey, Michael G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; AMPHETAMINE; BUCLADESINE; CENTRAL STIMULANT AGENT; COCAINE; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FORSKOLIN; GLUTAMATE RECEPTOR; ISOBUTYLMETHYLXANTHINE; PICROTOXIN; PRESYNAPTIC RECEPTOR; QUINPIROLE; ROLIPRAM; SULPIRIDE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; EXCITATORY POSTSYNAPTIC POTENTIAL; FOREBRAIN; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PATCH CLAMP; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0029864051     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.1996.sp021296     Document Type: Article

References (40)

1. 1 receptor efficacy. European Journal of Pharmacology 188, 335-348.
2. ANDERSEN, P. H., NIELSEN, E. B., SCHEEL KRUGER, J., JANSEN, J. A. & HOHLWEG, R. (1987). Thienopyridine derivatives identified as the first selective, full efficacy, dopamine DI receptor agonists. European Journal of Pharmacology 137, 291-292.
3. 2 dopamine receptors in rat forebrain by use of fluorescent ligands. Proceeding of the National Academy of Sciences of the USA 86, 8570-8574.
4. BEAVO, J. A. & REIFSNYDER, D. H. (1990). Primary sequences of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends in Pharmacological Sciences 11, 150-155.
5. 2 receptor antagonists differentially affect cocaine-induced locomotor hyperactivity in mouse. Psychopharmacology 105, 335-339.
6. CALABRESI, P., MERCURI, N. B., SANCESARIO, G. & BERNARDI, G. (1993). Electrophysiology of dopamine-denervated striatal neurons - implications for Parkinsons disease. Brain 116, 433-452.
7. 3H]GABA. Neuroscience 22, 425-439.
8. COLWELL, C. S. & LEVINE, M. S. (1995). Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms Journal of Neuroscience 15, 1704-1713.
9. DALY, J W., PADGETT, W. & SEAMON, K. B. (1982). Activation of cyclic AMP-generating systems in brain membranes and slices by the diterpene forskolin: augmentation of receptor-mediated responses. Journal of Neurochemistry 38, 532-540.
10. DEUTCH, A. Y. & CAMERON, D. S. (1992). Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46, 49-56.
11. FIBIGER, H. C. & PHILLIPS, A. G. (1986). Reward, motivation, cognition: psychobiology of mesentelencephalic dopamine systems. In Handbook of Physiology, section 1, The Nervous System, vol. IV, Intrinsic Regulatory Systems of the Brain, ed. MOUNTCASTLE, V B. & BLOOM, F. E., pp. 647-675. American Physiological Society, Bethesda, MD, USA.
12. 2 receptors on corticostriate terminals. Synapse 2, 521-531.
13. GOLDSTEIN, M. & DEUTCH, A. Y. (1992). Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB Journal 6, 2413-5421
14. 1 receptors. Society for Neuroscience Abstracts 21, 1568.
15. 3H]dopamine in rat brain tissue slices. Biochemical Pharmacology 24, 847-852.
16. HICASHI, H , INANAGA, K., NISHI, S. & UCHIMURA, N. (1989). Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment. Journal of Physiology 408, 587-603.
17. KELLY, P. H., SEVIOCR, P. W. & IVERSEN, K. D. (1970). Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Research 94, 507-522.
18. KNAPP, A. G., DOWLING, J. E., O'BRIEN, D. P & WHITE, F. J. (1987). Dopamine enhances excitatory amino acid-gated conductances in cultured retinal horizontal cells. Nature 142, 343-354.
19. KOMBIAN, S. B. & MALENKA, R. C. (1994). Simultaneous LTP of non-XMDA- and LTD of XMDA-receptor-mediated responses in the nucleus accumbens. Nature 368, 242-246.
20. KOOB, G. F. (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences 13, 177-184.
21. LAW-THO, D., DESCE, J. M. & CREPEL, F. (1995). Dopamine favours the emergence of long-term depression versus long-term potentiation in slices of rat prefrontal cortex. Neuroscience Letters 188, 125-128.
22. 2+ mobilization in Xenopus oocytes. Proceedings of the National Academy of Sciences of the USA 87, 2196-2200.
23. O'DONNELL, P. & GRACE, A. A. (1993a). Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens. Journal of Neuroscience 13, 3456-3471.
24. O'DONNELL, P. & GRACE, A. A. (1993a). Physiological and morphological properties of accumbens core and shell neurons recorded in vitro. Synapse 13, 135-160.
25. 2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Research 634, 105-112.
26. PENNARTZ, C. M. A., DOLLEMAN-VAN DER WEEL, M. J., KITAI, S. T. & LOPES DA SILVA, F. H. (1992a). Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro. Journal of Neurophysiolgy 67, 1325-1334.
27. PENNARTZ, C. M. A., DOLLEMAN-VAN DER WEEL, M. J & LOPES DA SILVA, F. H. (1992b). Differential membrane properties and dopamine effects in the shell and core of the rat nucleus accumbens studied in vitor. Neuroscience Letters 136, 109-112.
28. PIJNENBERG, A. J. J. & VAN ROSSUM, J. M. (1973) Stimulation of locomotor activity following injections of dopamine into the nucleus accumbens. Journal of Pharmacy and Pharmacology 25, 1003-1005.
29. PRALONG, E. & JONES, R. S. G. (1993). Interactions of dopamine with glutamate-mediated and GABA-mediated synaptic transmission in the rat entorhinal cortex at vitro European Journal of Neuroscience 5, 760-767.
30. ROWLANDS, G. J. & ROBERTS, P. J. (1980). Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro. European Journal of Pharmacology 62, 241-242.
31. SCHWARTZ, J.-C., GIROS, B., MARTRES, M.-P. & SOKOLOFF, P. (1992). The dopamine receptor family: molecular biology and pharmacology. Seminars in the Neurosciences 4, 99-108.
32. SMITH, D. O., LOWE, D., TEMKIN, R., JENSEN, P. & HATT, H. (1995). Dopamine enhances glutamate-activated currents in spinal motoneurons. Journal of Neuroscience 15, 13905-3912.
33. STOOF, J. C. & KEBABIAN, J. W. (1981). Opposing roles tor D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294, 366-308.
34. 1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14, 385-397.
35. SURMEIER, D. J., EBERWINE, J., WILSON, C. J., CAO, Y., STEFANI, A. & KITAI, S. T. (1992). Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proceedings of the National Academy of Sciences of the USA 89, 10178-10182.
36. UCHIMURA, N., CHERUBINI, E. & NORTH, R. A. (1989). Inward rectification in rat nucleus accumbens neurons. Journal of Neurophysiology 62, 1280-1286
37. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. Journal of Neurochemistry 62, 2045-2048.
38. WIECZOREK, W. J. & KRUK, Z. L. (1994). Differential action of (+)-amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens. British Journal of Pharmacology 111, 829-836.
39. WISE, R. A. & BOZARTH, M. A. (1987) A psychomotor stimulant theory of addiction. Psychological Review 94, 469-492.
40. XU, M., MORATALLA, R., GOLD, L. H., HIROI, X., KOOB, G. F., GRAYBIEL, A. M. & TONEGAWA, S. (1994). Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79, 729-742.